Icon
+91 94997 68112
Login Register

Accuneb - (Eq 0.021, Base; Solution, Inhalation)

Albuterol Sulfate Mylan
Eq 0.021, Base; Solution, Inhalation
Less Than $1000 mn
Less Than 5
Less Than 5
None None
Less Than 5
Less Than 5
AccuNeb is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease).
Yes
****** *** ******* *** ***** ** **** **** **. ****** ******** *** ******* ***** *** **** *********** ****** ** *** ***** *********. ******* *** *** ***** ********* *** ******** *** ******* ** ***** ****. ********* **** ***** **** **, *** ********* ***** ********** *** ***** *******. ** *** ******** *** ******** *** ******* ** ***** ****.
Accuneb Patent 1
****** *** *********
******* *** *********
********* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ *** [*** **** *********** *** *.***% ********] *** ********* *** ********* ******** ******** ** **** ****
******* *** \ ** *** ********* *** ********* ******** ******** ** ***** **, ****
********* ** \ ** ***** **, **** ******* ******** ************ ******** ** *** ****
  1. *** **, **** : ******* ******** ******** *** ** ** **** ******** *** *** **** *********** *** *.***% ********, ********* ** **** ** ***-*** *********** *******
  2. *** **, **** : ****** ******** ******** *** ** ** **** ******** *** *** **** *********** *** *.***% ********, ********* ** **** ** ***-*** *********** *******. *****://***.********.***/*******/********/******-***************-***-********-***-********-***-*******-*******-*-/
  3. *** *, **** : ********* ******** ***** ***** **'* **** ** ****** ** ****** ******* (*** **, ****)
  4. *** **, **** : ***** ***** * **** ******* ********* ** ****** ******* (*** **, ****)
  5. *** **, **** : ********** ********* **** *********, ***** *** ***** ** ********* *** *** *****
  6. *** **, **** : ********* ******** ***** ******** *** ******** *** *******.

Accuneb - (Eq, 0.042% base; solution, inhalation)

Albuterol Sulfate Mylan
Eq, 0.042% base; solution, inhalation
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
Less Than 5
Less Than 5
AccuNeb is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease).
Yes
******* ** ***** ** **** **** ** *** ****** *** ******* ***** *** **** *********** ****** ** *** ***** *********. ****** *** ***** **** **, *** ***** ********* *** ******** *** ******* ** *** ****. ********* **** ***** **** **, *** ********* ***** ********** *** ***** *******. ** *** ******** *** ******** *** ******* ** ***** ****.
Accuneb Patent 1
****** *** *********
******* *** *********
********* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** **\** ** *** ********* ******** ******** ** *** **, ****
******* *** \ *** [*** *** *********** *** *.***% ********] ** *** ********* ******** ******** ** *** **, ****
********* **\** ***** **, **** ******* ******** ************ ******** ** *** **, ****
  1. *** *, **** : * **** ** ** ***** *** ******* ** ******* *** *******
  2. *** **, **** : ******* ******** ******** *** ** ** **** ******** *** *** **** *********** *** *.***% **** ******** ** *** **** ** *** - **** *********** *******
  3. *** **, **** : ****** ******** ******** *** *.***% **** ********
  4. *** *, **** : ********* ******** ***** ** *** **** ** ****** ** ****** ******* (*** **, ****)
  5. *** **, **** : ***** ***** * **** ******* ********* ** ****** *******
  6. *** **, **** : ********** ********* **** ********* ***** ***** ** ********* *** *** *****
  7. *** **, **** : ********* ******** ******** *** *.***% **** ******** *** ******** *** *******

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.